Get the Stockscreener App
6.18
0.03%
-0.0019
Telomir Pharmaceuticals Inc stock is currently priced at $6.18, with a 24-hour trading volume of 21,183.
It has seen a -0.03% decreased in the last 24 hours and a -27.12% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $6.20 pivot point. If it approaches the $6.00 support level, significant changes may occur.
Previous Close:
$6.1819
Open:
$6.4
24h Volume:
21,183
Market Cap:
$182.99M
Revenue:
-
Net Income/Loss:
$-13.08M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.56%
1M Performance:
-27.12%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1D Range:
$6.021
$6.51
52W Range:
$4.76
$20.72
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Name
Telomir Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Telomir Pharmaceuticals Inc Stock (TELO) Latest News
Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, - Daily Guardian Canada
Daily Guardian Canada
Global Smart Building Market Poised to Surpass USD 165 Billion by 2029, Fueled by Technological Advancements - Daily Guardian Canada
Daily Guardian Canada
Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards ... - Yahoo Finance UK
Yahoo Finance UK
Coffee Prices Post Moderate Losses as ICE Coffee Inventories Rebound - Barchart
Barchart
Degenerative Disc Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key ... - Barchart
Barchart
US Inflation Eased In April In The First Slowdown Of 2024 - Barchart
Barchart
Telomir Pharmaceuticals Inc Stock (TELO) Financials Data
Telomir Pharmaceuticals Inc (TELO) Net Income 2024
TELO net income (TTM) was -$13.08 million for the quarter ending December 31, 2023.
Telomir Pharmaceuticals Inc (TELO) Earnings per Share 2024
TELO earnings per share (TTM) was -$0.4416 for the quarter ending December 31, 2023.
0.77%
1.20%
Cap:
|
Volume (24h):